Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001326389-25-000192·Drugs Made In America Acquisition Corp.
Schedule 13G ownership disclosure
DRUGS MADE IN AMER ACQUTN CO
Ordinary Shares · CUSIP: G2847J104
Event date: 2025-03-31
- Filing-level shares
- 1,900,000
- Percent of class
- 5.7%
- Polar Asset Management Partners Inc.
Shares: 1,900,000 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001326389-25-000192
- Form type
- SCHEDULE 13G
- Filer
- Drugs Made In America Acquisition Corp.
- CIK
- CIK 2028614
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership